Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival

This study aimed to identify aberrantly methylated differentially methylated CpG sites (DMCs) and investigate their prognostic value in hepatocellular carcinoma (HCC). A total of 2,404 DMCs were selected from Gene Expression Omnibus (GEO) and validated by The Cancer Genome Atlas (TCGA). The TCGA coh...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Guan, Renguo, Guo, Weimin, Hong, Weifeng, Lin, Ye, Zou, Xiongfeng, Shi, Ning, Yang, Dongyang, Zhou, Yu, Jian, Zhixiang, Jin, Haosheng, Lin, Weidong, Yu, Min
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390903/
https://ncbi.nlm.nih.gov/pubmed/32793465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01031
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia